These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26878893)

  • 21. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
    Izawa MO; Miwa H; Kajimoto Y; Kondo T
    Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
    Alonso-Canovas A; Tembl Ferrairó JI; Martínez-Torres I; Lopez-Sendon Moreno JL; Parees-Moreno I; Monreal-Laguillo E; Pérez-Torre P; Toledano Delgado R; García Ribas G; Sastre Bataller I; Masjuan J; Martinez-Castrillo JC; Walter U
    Parkinsonism Relat Disord; 2019 Nov; 68():40-45. PubMed ID: 31621617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: complementary role in the diagnosis of Parkinson's disease.
    Kajimoto Y; Miwa H; Okawa-Izawa M; Hironishi M; Kondo T
    Parkinsonism Relat Disord; 2009 May; 15(4):270-2. PubMed ID: 18691928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ultra early diagnosis of Parkinson's disease by the enhanced substantia nigra echo.
    Zhuang JJ; Zheng YH; Xu XW; Zhou L
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4621-6. PubMed ID: 26698260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography.
    Becker G; Seufert J; Bogdahn U; Reichmann H; Reiners K
    Neurology; 1995 Jan; 45(1):182-4. PubMed ID: 7824114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson's disease: A diagnostic performance study and meta-analysis.
    Hirata FCC; Sato JR; Vieira G; Lucato LT; Leite CC; Bor-Seng-Shu E; Pastorello BF; Otaduy MCG; Chaim KT; Campanholo KR; Novaes NP; Melo LM; Gonçalves MR; do Nascimento FBP; Teixeira MJ; Barbosa ER; Amaro E; Cardoso EF
    Eur Radiol; 2017 Jun; 27(6):2640-2648. PubMed ID: 27709279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential Tremor.
    Richter D; Woitalla D; Muhlack S; Gold R; Tönges L; Krogias C
    J Neuroimaging; 2017 Sep; 27(5):524-530. PubMed ID: 28426143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor.
    Sprenger FS; Wurster I; Seppi K; Stockner H; Scherfler C; Sojer M; Schmidauer C; Berg D; Poewe W
    Mov Disord; 2016 Apr; 31(4):579-83. PubMed ID: 26893155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early diagnosis of Parkinson's disease.
    Gaenslen A; Berg D
    Int Rev Neurobiol; 2010; 90():81-92. PubMed ID: 20692495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the substantia nigra by means of transcranial ultrasound imaging].
    Vivo-Orti MN; Tembl JI; Sastre-Bataller I; Vazquez-Costa JF; Sahuquillo P; Burguera JA
    Rev Neurol; 2013 Mar; 56(5):268-74. PubMed ID: 23440754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcranial sonography as a diagnostic tool for Parkinson's disease: a pilot study in the city of Rio de Janeiro, Brazil.
    Fernandes Rde C; Rosso AL; Vincent MB; Silva KS; Bonan C; Araújo NC; Berg D
    Arq Neuropsiquiatr; 2011 Dec; 69(6):892-5. PubMed ID: 22297874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcranial sonography findings in welding-related Parkinsonism in comparison to Parkinson's disease.
    Walter U; Dressler D; Lindemann C; Slachevsky A; Miranda M
    Mov Disord; 2008 Jan; 23(1):141-5. PubMed ID: 17987651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.
    Berg D
    J Neural Transm (Vienna); 2006 Jun; 113(6):775-80. PubMed ID: 16755382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.
    Laučkaitė K; Rastenytė D; Šurkienė D; Vaitkus A; Sakalauskas A; Lukoševičius A; Gleiznienė R
    BMC Neurol; 2012 Mar; 12():12. PubMed ID: 22400906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study on the diagnostic value of positron emission tomography and transcranial sonography in the diagnosis of Parkinson's disease].
    Li X; Feng T; Ouyang QH; Zhang HX; Li F
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(25):1944-7. PubMed ID: 24169240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A baseline study for detection of Parkinson's disease with 3D-transcranial sonography and uni-lateral reconstruction.
    Plate A; Maiostre J; Levin J; Bötzel K; Ahmadi SA
    J Neurol Sci; 2019 Feb; 397():16-21. PubMed ID: 30579060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.